American Healthcare REIT price target raised to $45 from $37 at Morgan Stanley

Morgan Stanley raised the firm’s price target on American Healthcare REIT (AHR) to $45 from $37 and keeps an Overweight rating on the shares. Senior housing occupancy and pricing is “off to one of the best years on record,” but senior housing may still have more upside given supply and demand fundamentals, the analyst tells investors in a note analyzing fundamentals across senior housing, life science and outpatient medical REITs.